Kwang Dong Pharmaceutical co., ltd.

6 clinical trials · Sponsor

Record	Firm	Date
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) (NCT04943068)	Kwang Dong Pharmaceutical co., ltd.	2021-05-10

Every clearance here is in the API, with alerts when new ones post.